The T cell response was studied in 25 patients suffering from cutaneous leishmaniasis caused by Leishmania major with severe (n = 10) and mild (n = 15) disease manifestations. Peripheral blood mononuclear cells (PBMC) from the patients were activated by sonicates of Leishmania promastigotes (LMP) and amastigotes (LDA), and the surface protease gp63. The proliferative responses to Leishmania antigens were lower in patients with severe disease than in patients with mild disease (P = 0 01-0-05), and such a difference was not observed in the response to purified protein derivative of tuberculin (PPD) or tetanus toxoid (TT). LMP-induced interferon-gamma (IFN--y) production was lower in patients with severe than in patients with mild disease (P < 0 05).
INTRODUCTION
Members of the genus Leishmania are protozoan parasites infecting and multiplying inside the phagolysosomes of macrophages in the mammalian host. Diseases caused by Leishmania parasites, the leishmaniases, constitute serious health problems, which affect millions of people in the tropical and subtropical parts of the world [1] . The clinical manifestations of leishmaniasis range from self-healing cutaneous ulcers (cutaneous leishmaniasis) to fatal systemic disease (visceral leishmaniasis, kala-azar) depending on the infecting parasite species and the immune response of the host [2] .
The most common clinical manifestation of L. major is simple cutaneous leishmaniasis (CL) characterized by an
Correspondence: Thor Theander, Centre of Medical Parasitology, Panum Building 24.2, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark. ulcerated lesion(s) which heals spontaneously leaving depressed scar(s) and long-lasting immunity [3] . However, in some patients complications may occur as the parasite metastasizes through the lymphatics to the lymph node, leading to the formation of subcutaneous nodules and/or enlargement of the regional lymph nodes [4, 5] . Severe disfigurement might result from large ulcers. Recently, an epidemic of CL hit the central Sudan along the Nile River in Greater Khartoum and spread to the North [6, 7] . The disease was caused by L. major zymodeme LON-1 [8, 9] .
In experimental murine models the outcome of L. major infection depends on the activation of one of the two subsets of T helper/inducer cells, Thl and Th2 [10] . Thl [11, 12] .
We have previously shown that both Thl-and Th2-like T cell reactivity exist in individuals who have been drug cured from visceral leishmaniasis caused by L. donovani [13, 14] . Th2-like cytokine production profiles have been demonstrated in T cells from peripheral blood [15] and bone marrow [16] of patients suffering from kala azar. We have also shown that the Leishmania-specific T cells of individuals recovered from uncomplicated CL were of the Thl-like subset [17] . In this study we describe the cytokine production pattern in patients suffering from mild and severe CL, and report that the presence in peripheral blood of Leishmania-specific T cells with ThI-like cytokine production profile is associated with mild disease, whereas the absence or scarcity of Thl activity and the presence of Th2 activity is associated with severe disease. [20] . Briefly, U937 cells were grown. Before infection the cells were transferred to tissue culture plates (Nunc, Roskilde, Denmark) at 1 x 106 cells/ml and stimulated by phorbol 12-myristate 13-acetate (PMA), causing cells to differentiate and grow as a monolayer. U937 cells were infected for 24 h at a parasite:cell ratio of 10:1 followed by washing to remove extracellular parasites. After 6 days of incubation at 37°C, the U937 cells were harvested. Amastigote purification was performed as described [21] by homogenization of the cells, followed by differential filtration through polycarbonate filters of decreasing pore size (Isopore; Millipore, Bedford, MA). Purified amastigotes were washed three times before sonication for 5 x 45 s (MSE-150; Soniprep, Crawley, UK). Soluble antigens were collected after centrifugation (30 min, 30 000g, 4°C) , and stored at -80°C until used at a final protein concentration of 13 Mg/ml.
PATIENTS AND METHODS
The abundant surface protein gp63 was purified from L. major promastigotes as described [22] . The protease activity of gp63 was inactivated by heating to 70°C for 20 min and the protein was used at a final concentration of 10 jig/ml.
Purified protein derivative of tuberculin (PPD) and tetanus toxoid (TT) were purchased from Statens Seruminstitut (Copenhagen, Denmark) and used at 12jig/ml and 3 jig/ml, respectively.
Lymphoproliferation and cytokine production Cells were cultured in RPMI 1640 with 10 mm HEPES, 20 U penicillin and 20 ,ig streptomycin per ml supplemented by 15% heat-inactivated, pooled, normal human serum (NHS). The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2. PBMC were incubated with antigen at 6-6 x 105 cells/ml in volumes of 170,u1 in round-bottomed microculture plates (Nunc). The cultures were incubated for 7 days and pulsed with 20 kl/well of 3H-thymidine (New England Nuclear, Boston, MA) (185 MBq/ml) for the last 24 h of incubation. The culture supernatants were recovered and stored at -20'C for later determination of IFN-7y. The cells were harvested onto glassfibre filters and the incorporation of 3H-thymidine into DNA was determined by a Matrix f3-counter (Packard, Greve, Denmark). All proliferation assays were performed in triplicate. For For the measurement of IL-4 release by antigen-stimulated cultures of PBMC, parallel cultures were carried out for 6 days and then pulsed with 1 sM ionomycin and 50 ng/ml PMA (both from Sigma, St Louis, MO) for 24 h before the culture supernatant from triplicate wells was harvested [23] .
Cytokine measurements IFN-y and IL-4 in the culture supernatants pooled from the triplicate cultures were measured by ELISA as described elsewhere [19, 23] . The detection ranges of the ELISAs were: 1-66 U/ml for IFN--y (specific activity of the reference protein:
2 5 x 108 U/mg) and 30-2000 pg/ml for IL-4. Antigen-induced cytokine production was calculated as the difference between antigen-stimulated and unstimulated cultures. A response was considered measurable if the SI (cytokine level in supernatant from antigen-stimulated culture/cytokine level in supernatant from cultures without antigen) was > 2-0.
Statistical analysis
The magnitude of the responses in patients with mild and severe disease were compared by the Mann-Whitney two-sample rank sum test. The Fisher exact test was used to compare the frequency of Thl and non-Thl responders in patients with severe and mild disease. P < 0.05 was considered significant.
RESULTS

Clinicalfeatures
Most patients were from villages of Khartoum region or from the outskirts of Omdurman City. The patients were divided into a group with mild and a group with severe disease according to the size of the lesion, duration of the disease and the presence of subcutaneous nodules. Table 1 summarizes the clinical information of the two groups. The groups were comparable with regard to age and number of lesions. The lesions were typically nodular or noduloulcerative, and usually involved the upper or lower limb. In 32% of the patients subcutaneous nodules, which usually followed the lymphatics draining into the regional lymph nodes, were present.
Proliferative responses
The proliferative responses of PBMC isolated from patients with severe and mild disease and of Danish controls presumably not previously exposed to L. major are summarized in 
IL-4 and IFN--y assays
The IFN-7y response to the Leishmania antigens was lower in the group with severe than in the group with mild disease (Table  3) , but only the difference in the response to promastigote sonicate reached statistical significance (P < 0-05). The PBMC from Danish donors did not produce IFN--y in response to gp63 or LDA. Some Danes produced IFN--y in response to LMP, and the IFN--y response to LMP in Danes and patients with severe disease was similar.
The IFN--y response to PPD was comparable in patients and controls. The TT response was higher in the patients with mild disease than in the two other groups, but the difference was not statistically significant. The difference between the Table 3 . Antigen-induced IFN--y production (median U/ml (95% confidence interval)) of peripheral blood mononuclear cells (PBMC) from patients with severe and mild cutaneous leishmaniasis (CL) and non-exposed Danish controls
Severe CL (n = 10) Mild CL (n = 15) Danes (n = 9) Antigen IFN--y (U/ml) IFN-,y (U/ml) IFN-y (U/ml) Severe CL (n = 10) Mild CL (n = 15) Danes (n = 9) Antigen IL-4 (pg/ml) IL-4 (pg/ml) IL-4 (pg/ml) (Fig. 1): (i) those with a considerable IFN-7y production and no IL-4 (Thl-like); and (ii) those with lacking or moderate IFN--y production often associated with some IL-4 production (not Thl-like). Most of the patients with mild disease (open circles) showed a Thl-like responsiveness, as opposed to the patients with severe disease (closed circles), in whom a non-Thl-like response pattern was most frequent. When the response of the patients was defined as ThI-like and non-ThI-like on the basis of IFN--y production as indicated in Fig. 1 (dotted lines) , the fraction of patients with ThI-like response pattern to Leishmania antigens was higher among those with mild disease compared with those with severe symptoms (Table 4 ). responses to PPD and TT could not be divided into distinct response patterns, and no correlation between the responsiveness and disease severity was evident (Fig. 2) . DISCUSSION Leishmania parasites cause human disease ranging from selfhealing cutaneous ulcers to fatal systemic infections. In addition many individuals become infected without developing disease [24] [25] [26] [27] . CL caused by L. major is often an uncomplicated disease, characterized by a localized skin lesion which heals spontaneously. However, in some cases complications might occur as the infection results in large ulcers or spreads through the lymphatics to the lymph nodes. To correlate Thland Th2-like immune responses to the clinical disease, we attempted to identify patients who had difficulties in controlling inflammation and parasite multiplication. Hence patients with large lesions and a long clinical history and/or apparent spread of the parasite as evidenced by swelling of subcutaneous nodules were defined as suffering from severe disease. This classification of the patients is probably not accurate. For instance, a patient with mild disease might later develop severe symptoms, and signs of severity could be caused by complications due to secondary infections. There was a higher proportion of men in the group with severe CL than in the group with mild disease. Furthermore, the duration of disease was shorter among the women than among the men (data not shown). These differences might be due to a tendency for women to seek treatment earlier than men.
The proliferative response to Leishmania antigens was lower in PBMC from patients with severe disease than in PBMC from patients with mild disease. This finding is in agreement with the findings by Jaffe etal. [28] and Frankenburg etal. [29] , who reported on Leishmania antigen-specific proliferative response in patients with mild CL caused by L. major, and the findings of Castes et al., and Caceres-Dittmar et al., who found that Leishmania antigen-induced PBMC proliferative response correlated with disease severity in South American patients suffering from CL [30] [31] [32] . The Danish controls did not respond to LDA and gp63 antigen, wkhereas LMP as reported previously [33, 34] activated the PBMC of some non-exposed donors.
Leishmania antigen-induced IFN-,y responses were higher in patients with mild than in patients with severe disease, and the F(c). difference was statistically significant when comparing the responses to LMP (P < 0-05). The difference in the capacity to produce IFN--y is interesting, since IFN-7 is a key factor in activating macrophages to kill the parasite [35, 36] , and exogenous IFN--y has been found efficient in the treatment of CL [37] and in combination with pentavalent antimony in the treatment of visceral leishmaniasis (VL) [38] . Evidence is accumulating that a Thl/Th2 dichotomy in the T cell response to Leishmania exists in humans [13] [14] [15] [16] [17] *Thl-like responsiveness was defined according to the production of IFN--y (Fig. 1) . ** Number statistically significantly higher than in patients with severe disease (*P = 0-049; **P = 0-034, Fisher's exact test). investigated skin biopsies obtained from patients suffering L. braziliensis infections, and found increased levels of mRNA coding for IL-2, IFN--y and lymphotoxin in patients with localized CL, and high levels of mRNA for IL-4 in patients with mucocutaneous manifestations.
In conclusion, we found that the in vitro function of PBMC of patients suffering from CL differed between those with mild and those with severe disease manifestations. Leishmania antigen-induced proliferation and IFN--y production were lower in the patients with severe disease than in the patients with mild disease. Moreover, Leishmania-induced cytokine production of each patient fell into one of two patterns, characterized as Thl-like or non-Thl-like. A Thl-like response pattern was associated with mild disease manifestations.
